北京大学医学部机构知识库
Advanced  
IR@PKUHSC  > 北京大学第二临床医学院  > 血液科  > 期刊论文
学科主题: 临床医学
题名:
Multicenter, Randomized, Open-Label Study Comparing the Efficacy and Safety of Micafungin versus Itraconazole for Prophylaxis of Invasive Fungal Infections in Patients undergoing Hematopoietic Stem Cell Transplant
作者: Huang, Xiaojun1; Chen, Huan; Han, Mingzhe2,3,4; Zou, Ping5; Wu, Depei6; Lai, Yongrong7; Huang, He8; Chen, Xiequn9; Liu, Ting10; Zhu, Huanling10; Wang, Jianmin11; Hui, Jianda12
关键词: Micafungin ; Itraconazole ; Prevention of invasive fungal infection ; Antifungal prophylaxis ; Hematopoietic stem cell transplant
刊名: BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
发表日期: 2012-10-01
DOI: 10.1016/j.bbmt.2012.03.014
卷: 18, 期:10, 页:1509-1516
收录类别: SCI
文章类型: Article
WOS标题词: Science & Technology
类目[WOS]: Hematology ; Immunology ; Transplantation
研究领域[WOS]: Hematology ; Immunology ; Transplantation
关键词[WOS]: ANTIFUNGAL PROPHYLAXIS ; NEUTROPENIC PATIENTS ; FLUCONAZOLE ; RECIPIENTS ; METAANALYSIS ; CHEMOTHERAPY ; MALIGNANCIES
英文摘要:

This multicenter, randomized, open-label phase III study compared the efficacy and safety of micafungin and itraconazole in prophylaxis of invasive fungal infections in neutropenic patients undergoing hematopoietic stem cell transplants in China. Micafungin (50 mg/day i.v.) or itraconazole (5 mg/kg/day p.o.) was administered for <= 42 days. The primary endpoint, treatment success, was defined as no proven, probable, or suspected invasive fungal infection through therapy and the absence of proven or probable invasive fungal infection through the end of 4 weeks after therapy. Noninferiority of micafungin against itraconazole was established if the lower boundary of the 95% confidence interval (CI) was >10%. Of 287 patients, 283 were evaluable for efficacy (136 for micafungin, 147 for itraconazole, intent-to-treat population). Treatment success was documented in 92.6% (126 of 136) of micafungin-treated patients and 94.6% (139 of 147) of itraconazole-treated patients (95% CI, -7.562% to 3.482%; P = .48), indicating noninferiority of micafungin against itraconazole. Results were similar for patients treated per protocol. Whereas the rates of proven or probable invasive fungal infection were numerically higher with micafungin than itraconazole at 4.4% (6 of 136) and 1.4% (2 of 147), rates of suspected invasive fungal infection were similar at 5.9% (8 of 136) and 7.5% (11 of 147), respectively. More patients treated with micafungin than itraconazole completed the study (82.9% versus 67.3%, respectively). Significant differences in incidence of withdrawal due to an adverse event (4.4% versus 21.1%) and drug-related adverse events (8% versus 26.5%) were shown between micafungin and itraconazole (P = .00, chi-square test). Micafungin was as effective as itraconazole in preventing invasive fungal infections in patients with neutropenia. In comparison to itraconazole, treatment tolerance was much better with micafungin. Biol Blood Marrow Transplant 18: 1509-1516 (2012) (C) 2012 American Society for Blood and Marrow Transplantation

语种: 英语
项目资助者: Astellas Pharma China, Inc.
WOS记录号: WOS:000309314100007
Citation statistics:
内容类型: 期刊论文
URI标识: http://ir.bjmu.edu.cn/handle/400002259/67724
Appears in Collections:北京大学第二临床医学院_血液科_期刊论文

Files in This Item:

There are no files associated with this item.


作者单位: 1.Soochow Univ, Affiliated Hosp 1, Suzhou, Peoples R China
2.Peking Univ, Peoples Hosp, Beijing Key Lab HSCT, Inst Hematol, Beijing 100044, Peoples R China
3.CAMS, Inst Hematol, Tianjin, Peoples R China
4.CAMS, Blood Dis Hosp, Tianjin, Peoples R China
5.PUMC, Tianjin, Peoples R China
6.Huazhong Univ Sci & Technol, Tongji Med Coll, Affiliated Union Hosp, Beijing, Peoples R China
7.Guangxi Med Univ, Affiliated Hosp 1, Nanning, Peoples R China
8.Zhejiang Univ, Sch Med, Affiliated Hosp 1, Hangzhou 310003, Zhejiang, Peoples R China
9.Fourth Mil Med Univ, Xijing Hosp, Xian 710032, ShaanXi, Peoples R China
10.W China Univ Med Sci, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China
11.Second Mil Med Univ, Changhai Hosp, Shanghai, Peoples R China
12.Fujian Med Univ, Affiliated Union Hosp, Fuzhou, Peoples R China

Recommended Citation:
Huang, Xiaojun,Chen, Huan,Han, Mingzhe,et al. Multicenter, Randomized, Open-Label Study Comparing the Efficacy and Safety of Micafungin versus Itraconazole for Prophylaxis of Invasive Fungal Infections in Patients undergoing Hematopoietic Stem Cell Transplant[J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION,2012,18(10):1509-1516.
Service
Recommend this item
Sava as my favorate item
Show this item's statistics
Export Endnote File
Google Scholar
Similar articles in Google Scholar
[Huang, Xiaojun]'s Articles
[Chen, Huan]'s Articles
[Han, Mingzhe]'s Articles
CSDL cross search
Similar articles in CSDL Cross Search
[Huang, Xiaojun]‘s Articles
[Chen, Huan]‘s Articles
[Han, Mingzhe]‘s Articles
Related Copyright Policies
Null
Social Bookmarking
Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit

Items in IR are protected by copyright, with all rights reserved, unless otherwise indicated.

 

 

Valid XHTML 1.0!
Copyright © 2007-2017  北京大学医学部 - Feedback
Powered by CSpace